CIK 0001393434 · Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $799,174
- in 9 filings, $788K under 10b5-1 plans
Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-24 | Hong Seung Suh Director | Grant or award | +12,000 | 32,933 | ||
| 2024-07-24 | Hong Seung Suh Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2024-07-24 | RAINES MERILEE Director | Grant or award | +12,000 | 32,933 | ||
| 2024-07-24 | RAINES MERILEE Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2024-07-24 | Williams Leslie J. Director | Grant or award | +12,000 | 37,433 | ||
| 2024-07-24 | Williams Leslie J. Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2024-07-24 | Warden Charles M Director | Grant or award | +12,000 | 72,464 | ||
| 2024-07-24 | Warden Charles M Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2024-07-24 | Graves Adrienne L Director | Grant or award | +12,000 | 36,000 | ||
| 2024-07-24 | Graves Adrienne L Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2024-06-01 | Waheed Nadia Chief Medical Officer | Grant or award | +141,666 | 141,666 | ||
| 2024-06-01 | Waheed Nadia Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +425,000 | 425,000 | ||
| 2024-05-23 | Nayak Sanjay Chief Strategy Officer | Sale 10b5-1 | −2,274 | $5.84 | $13K | 178,026 |
| 2024-05-23 | Dugel Pravin See Remarks | Sale 10b5-1 | −21,626 | $5.79 | $125K | 833,353 |
| 2024-02-27 | LINDSTROM RICHARD L MD Director | Option exercise | +18,939 | $8.80 | $167K | 139,341 |
| 2024-02-27 | LINDSTROM RICHARD L MD Director | Option exercise | +11,363 | $8.80 | $100K | 150,704 |
| 2024-02-27 | LINDSTROM RICHARD L MD Director | Option exercise · Stock Option (Right to Buy) | −18,939 | 0 | ||
| 2024-02-27 | LINDSTROM RICHARD L MD Director | Option exercise · Stock Option (Right to Buy) | −11,363 | 0 |
Page 8 of 8 · 158 trades